When used as part of a treatment regimen for NAFLD, GLP-1 medications help reduce liver fat accumulation through the following mechanisms: Weight Loss : GLP-1 medications promote weight loss, which is a key factor in reducing liver fat and inflammation
Administration should only be performed by trained healthcare professionals in a clinical environment, ensuring safety and efficacy throughout the process
Many people prescribed GLP1 drugs are not evaluated for psychological vulnerabilities that could make appetite suppression dangerous
States must cover all medically necessary treatments for this age group including GLP-1s for obesity when a provider determines theyre medically necessary
Below are some of the most commonly used GLP-1 medications: Dulaglutide (Trulicity) Exenatide (Bydureon BCise) Liraglutide (Saxenda, Victoza) Semaglutide (Ozempic, Rybelsus, Wegovy) Tirzepatide (Mounjaro, Zepbound) These medications differ in their dosing schedules, mechanisms of administration, and specific indications, but all work the same to improve blood sugar levels and support improved long-term health outcomes